References
- Parkin DM. The evolution of the population-based cancer registry. Nat Rev Cancer 2006;8:603–12.
- Bray F, Parkin DM. Evaluation of data quality in the cancer registry: Principles and methods. Part I: Comparability, validity and timeliness. Eur J Cancer 2009;5:747–55.
- Parkin DM, Bray F. Evaluation of data quality in the cancer registry: Principles and methods Part II. Completeness. Eur J Cancer 2009;5:756–64.
- Pedersen E, Magnus K. Cancer registration in Norway: The incidence of cancer in Norway 1953–54. Oslo: Norwegian Cancer Society; 1959.
- Tingulstad S, Halvorsen T, Norstein J, Hagen BR, Skjeldestad FE. Completeness and accuracy of registration of ovarian cancer in the Cancer Registry of Norway. Int J Cancer 2002;6:907–11.
- Harvei S, Tretli S, Langmark F. Quality of prostate cancer data in the cancer registry of Norway. Eur J Cancer 1996;1: 104–10.
- Helseth A, Langmark F, Mork SJ. Neoplasms of the central nervous system in Norway. I. Quality control of the registration in the Norwegian Cancer Registry. Apmis 1988;11:1002–8.
- Mork J, Moller B, Dahl T, Bray F. Time trends in pharyngeal cancer incidence in Norway 1981–2005: A subsite analysis based on a reabstraction and recoding of registered cases. Cancer Causes Control 2010;21:1397–405.
- Larsen IK, Smastuen M, Johannesen TB, Langmark F, Parkin DM, Bray F, . Data quality at the Cancer Registry of Norway: An overview of comparability, completeness, validity and timeliness. Eur J Cancer 2009;7:1218–31.
- Ault KA. Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: A combined analysis of four randomised clinical trials. Lancet 2007;9576:1861–8.
- Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, . Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;1:12–9.
- Hampl M, Sarajuuri H, Wentzensen N, Bender HG, Kueppers V. Effect of human papillomavirus vaccines on vulvar, vaginal, and anal intraepithelial lesions and vulvar cancer. Obstet Gynecol 2006;6:1361–8.
- van de Nieuwenhof HP, Massuger LF, van der Avoort IA, Bekkers RL, Casparie M, Abma W, . Vulvar squamous cell carcinoma development after diagnosis of VIN increases with age. Eur J Cancer 2009;5:851–6.
- Aho M, Vesterinen E, Meyer B, Purola E, Paavonen J. Natural history of vaginal intraepithelial neoplasia. Cancer 1991;1:195–7.
- van de Nieuwenhof HP, van der Avoort IA, de Hullu JA. Review of squamous premalignant vulvar lesions. Crit Rev Oncol Hematol 2008;2:131–56.
- Iversen T, Tretli S. Intraepithelial and invasive squamous cell neoplasia of the vulva: Trends in incidence, recurrence, and survival rate in Norway. Obstet Gynecol 1998;6:969–72.
- Tavassoli FA, Devilee P. World Health Organization Classification of Tumours. Pathology and genetics of tumours of the breast and female genital organs. Lyon: IARC Press; 2003.
- van Beurden M, ten Kate FJ, Smits HL, Berkhout RJ, de Craen AJ, van der Vange N, . Multifocal vulvar intraepithelial neoplasia grade III and multicentric lower genital tract neoplasia is associated with transcriptionally active human papillomavirus. Cancer 1995;12:2879–84.
- Sideri M, Jones RW, Wilkinson EJ, Preti M, Heller DS, Scurry J, . Squamous vulvar intraepithelial neoplasia: 2004 modified terminology, ISSVD Vulvar Oncology Subcommittee. J Reprod Med 2005;11:807–10.
- Havener L. Standards for cancer registries volume III: Standards for completeness, quality, analysis and management of data. Spriengfiled (IL): North American Association of Central Cancer Registries; 2004.
- Kreftregisteret. Masseundersøkelsen mot livmorhalskreft – Årsrapport; 2008.